Blood Borne Virus Tests, Instant results, Lab accuracy!

ScreenSafe are proud to introduce new instant reading test kits for Hepatitis C, Hepatitis B and HIV. These innovative cartridge devices can detect markers for the above Blood Borne Viruses from a drop of blood taken from a fingerprick, in the same way as a Diabetic person may test their blood sugar.
These could not only speed up the route to treatment for those who need it, they can save taxpayers money at the same time.
Traditionally, a Blood Borne Virus test in the drug treatment arena is carried out using a venous sample of blood, the newer dried blood spot method, or an oral swab back to lab. There is then a second appointment made some time later, in order to give the result time to come back from the lab. There are pros and cons to each of these methods which we will not discuss here, but the main benefits these devices have over all the others are speed and accuracy of result, and cost.
Almost everyone will have to wait for results at some point in their life and we all know how frustrating/anxious that can be. But there are added costs to waiting that most people are unaware of…administration, further appointment making to get the result, further staff time to give the result and anxiety on the side of the person waiting for it.
These devices could help to make a Blood Borne Virus screen one appointment only, with further investigation arranged or carried out, or health protection advice given, depending on the result, there and then.
Convenience to the individual – one appointment to remember, no anxious wait for your result, reliable accurate tests, find out your have negative staus status on the spot = immediate peace of mind, non-negative status = take action faster.
Convenience to the staff member – treat the client in half the appointment time, refer them quicker, no missed second appointments, no waiting for admin to transfer the lab result through to you, no having to chase lab results, hit targets for screening quicker.
And for the taxpayer – half the staff time cost, quicker screening helps to protect the wider community from risk of disease spread and therefore lower treatment costs, and cost effective screening devices help lower the cost of screening itself. Everyone benefits!
Accuracy wise – compared to laboratory screening of the same sample.
Hep C Antibody device – 100% compliance (sample size 2127)
Hep B surface Antibody – 100% compliance (sample size 851)
Hep B surface Antigen – 100% compliance (sample size 2190)
HIV Antibody (1/2/O) – 100% compliance (sample size 2210).
Does this mean they are 100% accurate? No, it matches the lab testing it was up against 100%. No test is believed to be 100% accurate, but these results show a very good level of performane against tried and trusted methods of screening for Blood Borne Viruses.
More to follow soon.